Old wine in new bottles: Reviving old therapies for alopecia areata using rodent models

Journal of Investigative Dermatology Symposium Proceedings

Volumn 8, Issue 2, 2003, Pages 212-216

  Tang, Liren ^a   Sundberg, John P ^b   Lui, Harvey ^a   Shapiro, Jerry ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JACKSON LABORATORY   (United States)

Author keywords

Anthralin; Autoimmunity; Cytokines; Mechlorethamine

Indexed keywords

CHLORMETHINE; CYTOKINE; DITHRANOL;

ALOPECIA AREATA; ANIMAL MODEL; CELL ACTIVITY; CONFERENCE PAPER; DERMATITIS; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; ERYTHEMA; HUMAN; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RODENT; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0141525466     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1087-0024.2003.00812.x     Document Type: Conference Paper

References (53)

1. Arrazola JM, Sendagorta E, Harto A, Ledo A: Treatment of alopecia areata with topical nitrogen mustard. Intern J Dermatol 24:608-610, 1985
2. Becker JC, Varki N, Bröcker EB, Reisfield RA: Lymphocyte-mediated alopecia in C37BL/6 mice following successful immunotherapy for melanoma. J Invest Dermatol 107:627-632, 1996
3. Bernardo O, Tang L, Lui H, Shapiro J: Topical nitrogen mustard in the treatment of alopecia areata. J Am Acad Dermatol in press
4. Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, DeProst Y: Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 114:112-116, 2000
5. Carroll JM, Crompton T, Seery JP, Watt FM: Transgenic mice expressing INF-γ in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol 108:412-422, 1997
6. Chodorowska G: Plasma concentration of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment. J Eur Acad Dermatol Venereol 10:147-151, 1998
7. Cope AP: Regulation of autoimmunity by proinflammatory cytokines. Curr Opin Immunol 10:669-676, 1998
8. Cork MJ, Crane AM, Duff-GW: Genetic control of cytokines: cytokine gene polymorphisms in alopecia areta. Dermatol Clin 14:671-178, 1996
9. Cork MJ, Tarlow JK, Clay FE, et al: An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata. J Invest Dermatol 104:15S-16S, 1995
10. Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock R: Combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 34:1022-1029, 1996
11. Engert A, Wolf J, Dieh V: Treatment of advanced Hodgkin's lymphoma: standard and experimental approaches. Sem Hematol 36:282-289, 1999
12. Esteve E, Bagot M, Joly P, et al: A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas: French Study Group of Cutaneous Lymphomas. Arch Dermatol 135:1349-1353, 1999
13. Feldmann M, Maini RN: Anti-TNF-α therapy of rheumatoid arthritis: what we have learned? Ann Rev Immunol 19:163-196, 2001
14. Fiedler-Weiss VC, Buys CM: Evaluation of anthralin in the treatment of alopecia areata. Arch Dermatol 123:1491-1493, 1987
15. Firestein GS: Novel therapeutic strategies involving animals, arthritis, and apoptosis. Curr Opin Rheumatol 10:236-241, 1998
16. Freyschmidt-Paul P, Sundberg JP, Happle R, McElwee KJ, Metz S, Boggess D, Hoffmann R: Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. J Invest Dermatol 113:61-68, 1999
17. Freyschmidt-Paul P, Ziegler A, McElwee KJ, Happle R, Kissling S, Sundberg JP, Hoffmann R: Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus). Eur J Dermatol 11:405-409, 2001
18. + T lymphocytes. Arch Dermatol 138:916-922, 2002
19. scid mice. J Invest Dermatol 117:1357-1362, 2001
20. Gilhar A, Shalaginov R, Assy B, Scrafimovich S, Kalish RS: Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101:62-67, 1998
21. Harris DR: Old wine in new bottles. The revival of anthralin. Cutis 62:201-203, 1998
22. Hoffmann R, Happle R: Does interleukin-1 reduce hair loss? Dermatol 191:273-275, 1995
23. Hoffmann R, Happle R: Topical immunotherapy in alopecia areata. What, how, and why? Dermatol Clin 14:739-744, 1996
24. Hoffmann R, Wenzel E, Huth A, van der Steen P, Schäufle M, Henninger H, Happle R: Cytokine mRNA levels in alopecia areata before and after treatment with contact allergen diphenylcyclopropenone. J Invest Dermatol 103:530-533, 1994
25. Joosten LAB, Lubberts E, Helsen MNA, van den Berg WB: Dual role of IL-12 in early and late stages of murine collagen type 11 arthritis. J Immunol 159:4094-4102, 1996
26. Kassiotis G, Kollias G: TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models. J Clin Invest 107:1507-1508, 2001
27. Lange RW, Germolec DR, Foley JF, Luster MI: Antioxidants attenuate anthralin-induced skin inflammation in BALB/c mice. Role of specific proinflammatory cytokines. J Leuk Biol 64:170-177, 1998
28. McDonagh AJG, Messenger AG: The pathogenesis of alopecia areata. Dermatol Clin 14:661-670, 1996
29. McElwee KJ, Boggess D, King LE, Sundberg JP: Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 111:797-803, 1999b
30. McElwee KJ, Rushton DH, Trachy R, Oliver RE: Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model. Br J Dermatol 137:491-497, 1997
31. + T cells restores hair growth in the DEBR model for alopecia areata. Br J Dermatol 135:211-217, 1996
32. + T cells. Br J Dermatol 140:432-437, 1999c
33. McElwee KJ, Tobin DJ, Bystryn JC, King LE, Sundberg JP: Alopecia areata: an autoimmune disease? Exp Dermatol 8:371-379, 1999a
34. Michie HJ, Jahoda CAB, Oliver RF, Johnson BE: The DEBR rat: an animal model of human alopecia areata. Br J Dermatol 125:94-100, 1991
35. Mrowietz U, Jessat H, Schwarz A, Schwarz T: Anthalin (dithranol) in vitro inhibits human monocytes to secrete IL-6, IL-8 and TNF-α, but not IL-1. Br J Dermatol 136:542-547, 1997
36. Nelson DA, Spielvogel RL: Anthralin therapy for alopecia areata. Int J Dermatol 24:606-607, 1995
37. Oliver RF, Lowe JG: Oral cyclosporin A restores hair growth in the DEBR rat model for alopecia areata. Clin Exp Dermatol 20:127-131, 1995
38. Perret C, Weisner-Menzel L, Happle R.: Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venereol 64:26-30, 1984
39. Philpott MP, Sanders DA, Bowen J, Kealey T: Effects of interleukins, colony-stimulating factor and tumor necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumor necrosis factor-α in alopecia areata. Br J Dermatol 135:942-948, 1996
40. Ramsay DL, Meller JA, Zackheim HS: Topical treatment of early cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 9:1031-1056, 1995
41. Randall VA: Is alopecia areata an autoimmune disease. Lanet 358:1922-23, 2001
42. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ: Incidence of alopecia arcata in Olmstead County, Minnesota 1975 through 1989. Mayo Clin Proc The 70:828-633, 1995
43. Shapiro J: Hair Loss. Principles of Diagnosis and Management of Alopecia. London: Martin Dunitz, 2002
44. Shapiro J, Price VH: Hair regrowth therapeutic agents. Dermatol Clin 16:341-356, 1998
45. Shapiro J, Sundberg JP, Bissonnette R, et al: Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone. J Invest Dermatol Sym Proc 4:239, 1999
46. Sundberg JP, Cordy WR, King LE Jr: Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 102:847-856, 1994
47. Sundberg JP, King LE Jr: Mouse models for the study of human hair loss. Dermatol Clin 14:619-632, 1996
48. Tang L, Cao L, Sundberg JP, Lui H, Shapiro J: Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Exp Dermatol 12:1-6, 2003a
49. Tang L, Cao L, Bernardo O, et al: Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes. J Invest Dermatol 120:400-406, 2003b
50. Tesch H, Sieber M, Diehl V: Treatment of advanced stage Hodgkin's disease. Oncol 60:101-109, 2001
51. Todes-Taylor NR, Turner BS, Wood BS, Staratte PT, Morhenn VB: T cell subpopulations in alopecia areata. J Am Acad Dermatol 11:216-223, 1984
52. Wiegrebe W, Muller K: Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives. Skin Pharmatol 8:1-24, 1995
53. Zhang JG, Oliver RF: Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata. Br J Dermatol 130:405-414, 1994